Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Another recall for metformin due to contamination | COVID-19 research and CV therapies | Cardiac resynchronization therapy
Friday, November 6, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Top Stories

FDA announces another recall for extended-release metformin due to contamination

Nostrum Laboratories is at the center of this latest voluntary recall. 

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces another recall for extended-release metformin due to contamination

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
Nostrum Laboratories is at the center of this latest voluntary recall. 
READ MORE >

Just 6.9% of COVID-related clinical trials are focused on cardiovascular therapies

The study's authors looked at nearly 3,000 clinical trials related to the ongoing pandemic. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Just 6.9% of COVID-related clinical trials are focused on cardiovascular therapies

Share on Twitter Share on Facebook Share on Linkedin
The study's authors looked at nearly 3,000 clinical trials related to the ongoing pandemic. 
READ MORE >

Cardiac resynchronization therapy benefits patients with severe LV dysfunction

No procedure-related deaths were reported, and an absolute LVEF improvement of more than 5% was present in nearly 49% of patients. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Cardiac resynchronization therapy benefits patients with severe LV dysfunction

Share on Twitter Share on Facebook Share on Linkedin
No procedure-related deaths were reported, and an absolute LVEF improvement of more than 5% was present in nearly 49% of patients. 
READ MORE >

Featured Articles

New-look implantable device can identify, treat heart disease

The patch harvests energy from each heartbeat, allowing it to operate with no external power source. 

READ MORE >
heart device patch
Share on Twitter Share on Facebook Share on Linkedin

New-look implantable device can identify, treat heart disease

Share on Twitter Share on Facebook Share on Linkedin
heart device patch
The patch harvests energy from each heartbeat, allowing it to operate with no external power source. 
READ MORE >

Training for cardiothoracic surgeons may be falling short in one key area

“The association between surgeon experience and operative outcomes has been the subject of debate," the researchers explained.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Training for cardiothoracic surgeons may be falling short in one key area

Share on Twitter Share on Facebook Share on Linkedin
“The association between surgeon experience and operative outcomes has been the subject of debate," the researchers explained.
READ MORE >

Obese men with type 2 diabetes face an increased risk of AFib

These findings are especially important, the authors wrote, because they suggest there may be a new way to personalize patient care. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Obese men with type 2 diabetes face an increased risk of AFib

Share on Twitter Share on Facebook Share on Linkedin
These findings are especially important, the authors wrote, because they suggest there may be a new way to personalize patient care. 
READ MORE >

From the Magazine

When Fear Goes Viral - What to Say to a Frightened Patient

SCAI’s president explains the key points she shares when reassuring patients who are reluctant to present for care.

READ MORE >
When Fear goes Viral
Share on Twitter Share on Facebook Share on Linkedin

When Fear Goes Viral - What to Say to a Frightened Patient

Share on Twitter Share on Facebook Share on Linkedin
When Fear goes Viral
SCAI’s president explains the key points she shares when reassuring patients who are reluctant to present for care.
READ MORE >

In Other News

Humana curtails coverage for PET/CT, drawing 'adamant' disagreement from imaging advocates

The American Society of Nuclear Cardiology is asking the Louisville, Kentucky-based commercial insurer to kill the payment policy change. 

READ MORE >
Humana
Share on Twitter Share on Facebook Share on Linkedin

Humana curtails coverage for PET/CT, drawing 'adamant' disagreement from imaging advocates

Share on Twitter Share on Facebook Share on Linkedin
Humana
The American Society of Nuclear Cardiology is asking the Louisville, Kentucky-based commercial insurer to kill the payment policy change. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

The real impact of RVU cuts in electrophysiology | TAVR changes on the way | Cardiology groups celebrate bill | BP drug recalled
Blood may leak out of Impella introducers | Leadless conduction and Bachmann's pacing | US study for microvascular disease
Top 10 most popular cardiology video interviews this past month
Week in Review: CCTA on ACC expo floor gives cardiologist wake-up call | Reaction to CMS TAVR changes | Recalls and new AI
CCTA scan provides a wake-up call | Resistance training & heart attack risk in women | New ultrasound tech | AFib & grout
FDA clears first surgical valve of its kind | Family files $17M lawsuit | BATMAN to the rescue | Major trends at SCCT 2026
Early reactions to proposed TAVR changes | Cardiology still an AI leader | More than 11K bottles of blood pressure drug recalled

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Page 2
    • Current page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme